| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
44
|
49 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
38
|
56 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
35
|
41 |
| PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
24
|
59 |
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
22
|
30 |
| MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
21
|
17 |
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
20
|
30 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
20
|
23 |
| LINC00461 |
|
long intergenic non-protein coding RNA 461
|
|
|
0.736 |
0.423 |
19
|
24 |
| ADAMTS9-AS2 |
|
ADAMTS9 antisense RNA 2
|
|
|
0.656 |
0.462 |
18
|
17 |
| ZMIZ1-AS1 |
|
ZMIZ1 antisense RNA 1
|
|
|
0.780 |
0.115 |
16
|
7 |
| LINC00511 |
|
long intergenic non-protein coding RNA 511
|
|
|
0.638 |
0.423 |
16
|
8 |
| LINC01505 |
|
long intergenic non-protein coding RNA 1505
|
|
|
0.821 |
0.192 |
15
|
25 |
| SPRY4-AS1 |
|
SPRY4 antisense RNA 1
|
|
|
0.890 |
0.192 |
15
|
15 |
| CASC8 |
|
cancer susceptibility 8
|
|
|
0.670 |
0.462 |
14
|
17 |
| LINC01524 |
|
long intergenic non-protein coding RNA 1524
|
|
|
0.839 |
0.192 |
13
|
16 |
| CCNT2-AS1 |
|
CCNT2 antisense RNA 1
|
|
|
0.931 |
0.115 |
11
|
9 |
| MIR100HG |
|
mir-100-let-7a-2-mir-125b-1 cluster host gene
|
|
|
0.682 |
0.308 |
11
|
11 |
| LINC01184 |
|
long intergenic non-protein coding RNA 1184
|
|
|
1.000 |
0.077 |
11
|
12 |
| PPIEL |
|
peptidylprolyl isomerase E like pseudogene
|
|
|
0.931 |
0.077 |
11
|
5 |
| SOCAR |
|
serous ovarian cancer associated RNA
|
|
|
0.821 |
0.231 |
10
|
9 |
| LINC02357 |
|
long intergenic non-protein coding RNA 2357
|
|
|
0.805 |
0.231 |
9
|
7 |
| HOTTIP |
|
HOXA distal transcript antisense RNA
|
|
|
0.575 |
0.654 |
8
|
9 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
8
|
4 |